Search the Newsreel

Quick Update On Take-Two Interactive Software Stock $TTWO - GTA 6 Might Be Delayed, But Who Cares?!🤪 Marshals (TTgj7Iy2Au)

Is Take-Two’s Grand Theft Auto VI‑Anchored Bookings Outlook Altering The Investment Case For Take-Two Interactive Software (TTWO)?

TTWO Stock Pops 6.35% As Analyst Flags Massive ‘GTA VI’ Launch Potential

Dockside LLC Makes New $3.77 Million Investment in Take-Two Interactive Software, Inc. $TTWO

Dockside LLC recently invested $3.77 million in Take-Two Interactive Software (NASDAQ:TTWO) by acquiring 15,070 shares. This comes as other institutional investors like Vanguard, State Street, and Geode also increased their holdings. Analysts maintain a consensus "Buy" rating for TTWO, despite the company missing EPS …

Nicola Greenway (TAK) plans sale of 12,980 Takeda ADSs after RSU vesting

Nicola Greenway has filed a notice to sell 12,980 American Depositary Shares (ADSs) of Takeda Pharmaceutical Company Limited, derived from vested Restricted Stock Unit Awards. The planned sale is scheduled for August 14, 2026, through Interactive Brokers LLC. This follows previous sales on August …

Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?

On July 30, Keros Therapeutics, Inc. (NASDAQ:KROS) triggered a $20 million development milestone payment from its global partner Takeda Pharmaceutical Company Limited (NYSE:TAK). The payout followed the first patient dosed in the Phase 3 ELRiSE MDS clinical trial, evaluating elritercept against epoetin alfa for …

Take-Two Interactive Software Inc. stock outperforms competitors on strong trading day

Take-Two Interactive Software Inc. (TTWO) saw its stock rise by 2.08% to $246.95 on Friday, outperforming the broader market. This gain occurred despite a grim trading session where the S&P 500 Index fell 0.17% and the Dow Jones Industrial Average fell 0.20%. The increase …

Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Take-Two Interactive Software, Inc. $TTWO

TAK|Takeda Pharmaceutical Co Ltd|Price:17.405|Chg%:-0.005

Nations Financial Group Inc. IA ADV Acquires Shares of 5,223 Take-Two Interactive Software, Inc. $TTWO

Nations Financial Group Inc. IA ADV has acquired 5,223 shares of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) valued at approximately $1.3 million during the second quarter. Despite missing EPS estimates, Take-Two reported strong revenue, and analysts maintain a "Buy" rating with an average price target …

SeaTown Holdings Pte. Ltd. Buys 24,250 Shares of Take-Two Interactive Software, Inc. $TTWO

SeaTown Holdings Pte. Ltd. significantly increased its stake in Take-Two Interactive Software (NASDAQ: TTWO) by 61.6% in Q2, acquiring 24,250 additional shares to hold 63,600 shares valued at approximately $15.9 million. While institutional investors own 95.46% of the company, insiders have recently sold over …

Takeda Pharmaceutical (TAK) executive reports sale of 20,363 ADS at $17.55

Shannon Elaine Mary, President of Global Supply & Quality at Takeda Pharmaceutical Co. Ltd. (TAK), sold 20,363 American Depositary Shares (ADS) at a price of $17.55 per ADS on August 11, 2026. This transaction was an open market or private sale, and after the …

Takeda Pharmaceutical (NYSE:TAK) Insider Andrew Stewart Plump Sells 165,393 Shares of Stock

Andrew Stewart Plump, an insider at Takeda Pharmaceutical (NYSE:TAK), sold 165,393 shares of the company's stock for approximately $2.83 million. This sale was conducted to cover tax obligations from vested equity awards, reducing his stake by 17.75%. Despite mixed analyst ratings, with a consensus …

Takeda (TAK) President IBU sells 31,083 ADSs in tax-related transaction

Giles Richard Platford, President, IBU of Takeda Pharmaceutical Co Ltd (TAK), sold 31,083 American Depositary Shares (ADSs) on August 10, 2026, at a weighted average price of $17.10 per share. This transaction was a mandatory sale to cover taxes associated with the vesting of …

(TTWO) as a Liquidity Pulse for Institutional Tactics

This analysis of Take-Two Interactive Software Inc. (NASDAQ: TTWO) highlights its potential as a liquidity pulse for institutional trading. AI models suggest strong near and mid-term sentiment, with specific trading strategies outlined for position trading, momentum breakouts, and risk hedging. The report also details …

Merit Financial Group LLC Grows Position in Take-Two Interactive Software, Inc. $TTWO

Merit Financial Group LLC significantly increased its stake in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) by 144.7% in Q2, bringing its total holdings to 8,537 shares valued at $2.13 million. Despite institutional investor confidence and a consensus "Buy" rating from analysts, the company reported an …

Have Take-Two Interactive Software Insiders Been Selling Stock?

Take-Two Interactive Software's Executive Chairman & CEO, Strauss Zelnick, recently sold US$10m worth of stock, reducing his holding by 16%. This follows an earlier sale of US$16m this year, both transactions occurring at prices below the current market value. While insiders own a significant …

Take-Two Interactive Software, Inc. $TTWO Shares Acquired by Empirical Capital Management LLC

Empirical Capital Management LLC significantly increased its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 380.2% in the second quarter, making it their largest holding. Other institutional investors also adjusted their positions in TTWO, which now has a consensus "Buy" rating and an average price …

Gabriele Ricci Sells 25,088 Shares of Takeda Pharmaceutical (NYSE:TAK) Stock

Takeda Pharmaceutical (NYSE:TAK) Insider Nicola Deidre Petal Greenway Sells 6,774 Shares of Stock

Takeda Pharmaceutical (NYSE:TAK) General Counsel Natalie Anne Marie Furney Sells 30,868 Shares of Stock

Takeda Pharmaceutical (NYSE:TAK) Insider Sells $392,564.70 in Stock

Agosti Marcello Pignagnoli, an insider at Takeda Pharmaceutical (NYSE:TAK), sold 22,957 shares worth $392,564.70 to cover tax obligations from vested equity awards, reducing his direct ownership by 11.48%. The company's shares are trading at $17.42 with a market cap of $55.82 billion, and analysts …

Insider Selling: Takeda Pharmaceutical (NYSE:TAK) Insider Sells $124,436.70 in Stock

Ramy Riad Ahmed Ibrahim, an insider at Takeda Pharmaceutical (NYSE:TAK), sold 7,277 shares of company stock worth $124,436.70. This transaction, which reduced his ownership by 6.62%, was primarily to cover tax obligations related to vested equity awards. The company's stock is currently trading near …

Takeda Pharmaceutical (NYSE:TAK) CEO Sells $1,523,439.00 in Stock

Takeda Pharmaceutical's CEO, Julie So-Young Kim, sold 89,090 shares of company stock for over $1.5 million to cover tax obligations from vested equity awards, reducing her ownership by 18.54%. The company's stock trades at $17.42 with a market cap of $55.82 billion, and analyst …

Elaine Mary Shannon Sells 3,978 Shares of Takeda Pharmaceutical (NYSE:TAK) Stock

Takeda Pharmaceutical (NYSE: TAK) executive sells 7,277 ADS in tax-related trade

Ramy Riad Ahmed, President of the PDT business unit at Takeda Pharmaceutical Co Ltd (NYSE: TAK), sold 7,277 American Depositary Shares (ADS) on August 10, 2026, at a weighted average price of $17.10 per share. This sale was mandatory to cover taxes related to …

Takeda (TAK) executive sells 25,088 ADSs in mandatory tax-related trade

Takeda Pharmaceutical Co Ltd's Chief Data & Tech. Officer, Gabriele Ricci, sold 25,088 American Depositary Shares (ADSs) on August 10, 2026, at a weighted average price of $17.10 per ADS. This transaction was a mandatory sale to cover tax obligations related to vested equity …

Takeda Pharmaceutical (NYSE: TAK) counsel sells 30,868 ADSs to cover taxes

Takeda Pharmaceutical's Global General Counsel, Natalie Anne Marie Furney, sold 30,868 American Depositary Shares (ADSs) on August 10, 2026, for a weighted average price of $17.10 per ADS. This transaction was a mandatory sale to cover tax obligations related to the vesting of equity …

Unity Software Stock Rebounds as Revenue Hits $508M [2026]

Unity Software reported strong Q1 2026 results, with revenue reaching $508.2 million, a 16.8% increase year-over-year, signaling a recovery after its 2023 Runtime Fee crisis. The company's guidance for Q2 2026 indicates continued double-digit growth, reinforcing investor confidence. This rebound is attributed to improved …

Why Take-Two Interactive Software (TTWO) Stock Is Down Today

J.P. Morgan Initiates Take-Two Interactive Software(TTWO.US) With Buy Rating, Announces Target Price $310

J.P. Morgan has initiated coverage on Take-Two Interactive Software (TTWO.US) with a "Buy" rating. The firm has set a price target of $310 for the video game publisher. This rating suggests J.P. Morgan's positive outlook on the company's stock performance.

Takeda Pharmaceutical (TSE:4502) Is Using AI To Advance Three Late Stage Medicines

Takeda Pharmaceutical (TSE:4502) Wins ORZEYFUL Approval, Where Does Fair Value Sit?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Takeda Pharmaceutical (TSE:4502) has drawn fresh attention after U.S. regulators approved ORZEYFUL for adult narcolepsy type 1, and the company also issued new impairment …